Disparities in HPV vaccination rates and HPV prevalence in the United States

a review of the literature

Research output: Contribution to journalReview article

Abstract

Human papillomavirus (HPV) is a common sexually transmitted infection which is the cause of several cancers, including cervical cancer, and genital warts. Although cervical cancer can be prevented through screening, this cancer persists in the US. More recently, HPV vaccination has the potential to decrease the burden of HPV-related disease among young HPV-unexposed adolescents. Several initiatives aimed to encourage HPV vaccination have been adopted. Unfortunately, uptake of the HPV vaccine remains modest, despite evidence that vaccine-type HPV prevalence is decreasing as a result of HPV vaccination. Further, geographic disparities in vaccination uptake across different US regions and by race/ethnicity may contribute to continuing disparities in HPV-related cancers. More data are needed to evaluate impact of HPV vaccination on HPV prevalence in smaller geographic areas. Further, more information is needed on the impact of individual vaccination programs and policy on population level vaccination and HPV prevalence.

Original languageEnglish (US)
Pages (from-to)146-155
Number of pages10
JournalHuman Vaccines and Immunotherapeutics
Volume15
Issue number1
DOIs
StatePublished - Jan 2 2019

Fingerprint

Vaccination
Papillomavirus Vaccines
Uterine Cervical Neoplasms
Condylomata Acuminata
Public Policy
Sexually Transmitted Diseases
Early Detection of Cancer
Neoplasms

Keywords

  • cancer
  • health disparities
  • HPV vaccination
  • primary cancer prevention

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this

Disparities in HPV vaccination rates and HPV prevalence in the United States : a review of the literature. / Hirth, Jacqueline.

In: Human Vaccines and Immunotherapeutics, Vol. 15, No. 1, 02.01.2019, p. 146-155.

Research output: Contribution to journalReview article

@article{b99c4d3c983a4a10af4cf6d5e0679cfe,
title = "Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature",
abstract = "Human papillomavirus (HPV) is a common sexually transmitted infection which is the cause of several cancers, including cervical cancer, and genital warts. Although cervical cancer can be prevented through screening, this cancer persists in the US. More recently, HPV vaccination has the potential to decrease the burden of HPV-related disease among young HPV-unexposed adolescents. Several initiatives aimed to encourage HPV vaccination have been adopted. Unfortunately, uptake of the HPV vaccine remains modest, despite evidence that vaccine-type HPV prevalence is decreasing as a result of HPV vaccination. Further, geographic disparities in vaccination uptake across different US regions and by race/ethnicity may contribute to continuing disparities in HPV-related cancers. More data are needed to evaluate impact of HPV vaccination on HPV prevalence in smaller geographic areas. Further, more information is needed on the impact of individual vaccination programs and policy on population level vaccination and HPV prevalence.",
keywords = "cancer, health disparities, HPV vaccination, primary cancer prevention",
author = "Jacqueline Hirth",
year = "2019",
month = "1",
day = "2",
doi = "10.1080/21645515.2018.1512453",
language = "English (US)",
volume = "15",
pages = "146--155",
journal = "Human Vaccines and Immunotherapeutics",
issn = "2164-5515",
publisher = "Landes Bioscience",
number = "1",

}

TY - JOUR

T1 - Disparities in HPV vaccination rates and HPV prevalence in the United States

T2 - a review of the literature

AU - Hirth, Jacqueline

PY - 2019/1/2

Y1 - 2019/1/2

N2 - Human papillomavirus (HPV) is a common sexually transmitted infection which is the cause of several cancers, including cervical cancer, and genital warts. Although cervical cancer can be prevented through screening, this cancer persists in the US. More recently, HPV vaccination has the potential to decrease the burden of HPV-related disease among young HPV-unexposed adolescents. Several initiatives aimed to encourage HPV vaccination have been adopted. Unfortunately, uptake of the HPV vaccine remains modest, despite evidence that vaccine-type HPV prevalence is decreasing as a result of HPV vaccination. Further, geographic disparities in vaccination uptake across different US regions and by race/ethnicity may contribute to continuing disparities in HPV-related cancers. More data are needed to evaluate impact of HPV vaccination on HPV prevalence in smaller geographic areas. Further, more information is needed on the impact of individual vaccination programs and policy on population level vaccination and HPV prevalence.

AB - Human papillomavirus (HPV) is a common sexually transmitted infection which is the cause of several cancers, including cervical cancer, and genital warts. Although cervical cancer can be prevented through screening, this cancer persists in the US. More recently, HPV vaccination has the potential to decrease the burden of HPV-related disease among young HPV-unexposed adolescents. Several initiatives aimed to encourage HPV vaccination have been adopted. Unfortunately, uptake of the HPV vaccine remains modest, despite evidence that vaccine-type HPV prevalence is decreasing as a result of HPV vaccination. Further, geographic disparities in vaccination uptake across different US regions and by race/ethnicity may contribute to continuing disparities in HPV-related cancers. More data are needed to evaluate impact of HPV vaccination on HPV prevalence in smaller geographic areas. Further, more information is needed on the impact of individual vaccination programs and policy on population level vaccination and HPV prevalence.

KW - cancer

KW - health disparities

KW - HPV vaccination

KW - primary cancer prevention

UR - http://www.scopus.com/inward/record.url?scp=85060905898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060905898&partnerID=8YFLogxK

U2 - 10.1080/21645515.2018.1512453

DO - 10.1080/21645515.2018.1512453

M3 - Review article

VL - 15

SP - 146

EP - 155

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

SN - 2164-5515

IS - 1

ER -